ID
15376
Beschrijving
Study documentation part: Discontinuation of Study medication Study short name: DIMAT MS Study Details: A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on ImmuneModulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis. Principal Investigator PD Dr. Luisa Klotz, University Hospital Münster EudraCT - No.: 2014-003481-25. Clinical Trial No.: NCT02461069.
Trefwoorden
Versies (1)
- 28-05-16 28-05-16 -
Geüploaded op
28 mei 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Discontinuation of Study medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis DRKS00008037 NCT02461069
Discontinuation of Study medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis NCT02461069
Beschrijving
Primary reason for discontinuation of study medication
Beschrijving
Patient requests discontinuation of Study Medication
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0332153
- UMLS CUI [1,2]
- C0558681
Beschrijving
Investigator determines that continuing it would result in a significant risk for that patient
Datatype
boolean
Alias
- UMLS CUI [1]
- C0420243
Beschrijving
Patient becomes pregnant
Datatype
boolean
Alias
- UMLS CUI [1]
- C0549206
Beschrijving
Patient withdraws informed consent
Datatype
boolean
Alias
- UMLS CUI [1]
- C1707492
Beschrijving
Lymphocyte count is < 500/μl, confirmed by two independent measurements 2 weeks apart
Datatype
boolean
Alias
- UMLS CUI [1]
- C1845611
Beschrijving
Leukocyte count is < 3,000/μl, confirmed by two independent measurements 2 weeks apart
Datatype
boolean
Alias
- UMLS CUI [1]
- C0948695
Beschrijving
Suspicion of a PML (progressive multifocal leukoencephalopathy)
Datatype
boolean
Alias
- UMLS CUI [1]
- C0023524
Beschrijving
Adverse event
Datatype
boolean
Alias
- UMLS CUI [1]
- C0877248
Beschrijving
Serious adverse event
Datatype
boolean
Alias
- UMLS CUI [1]
- C1519255
Beschrijving
Abnormal laboratory value(s) including liver function tests or abnormal test result(s)
Datatype
boolean
Alias
- UMLS CUI [1]
- C0438215
- UMLS CUI [2]
- C0151766
Beschrijving
Use of prohibited medications
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0138547
Beschrijving
Protocol deviation(s)
Datatype
boolean
Alias
- UMLS CUI [1]
- C1705236
Beschrijving
Unsatisfactory therapeutic effect
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1527144
- UMLS CUI [1,2]
- C0439856
Beschrijving
Patient's condition no longer requires study treatment
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1318598
- UMLS CUI [1,2]
- C0683521
Beschrijving
Administrative problems (e.g. patient's non-compliance)
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3469597
- UMLS CUI [1,2]
- C0033213
Beschrijving
Other reason
Datatype
text
Alias
- UMLS CUI [1]
- C3840932
Beschrijving
Signature
Similar models
Discontinuation of Study medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis NCT02461069
C0558681 (UMLS CUI [1,2])
C0151766 (UMLS CUI [2])
C0138547 (UMLS CUI [1,2])
C0439856 (UMLS CUI [1,2])
C0683521 (UMLS CUI [1,2])
C0033213 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])